Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Campbell Soup Co. (CPB) vs Koninklijke Philips NV (PHG) Price & Performance

Campbell Soup Co.Trade
Koninklijke Philips NVTrade

Price performance (Past 24H)

Key statistics

Campbell Soup Co. vs Koninklijke Philips NV — how do they compare? Campbell Soup Co. trades at $22.09 (market cap $6.59B), while Koninklijke Philips NV trades at $27.03 (market cap $25.47B). The key difference: Koninklijke Philips NV is far larger — about 3.9× Campbell Soup Co.'s market cap, and Campbell Soup Co. pays the higher dividend (7.06%). Which is the better fit depends on your goals.

CPBPHG
Market Cap
$6.59B$25.47B
Sector
Consumer StaplesHealth
52-Week High
$34.03$32.91
52-Week Low
$20.00$24.11
Enterprise Value
$13.20B$31.74B
Dividend Yield
7.06%3.89%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Campbell Soup Co.

Campbell's (CPB) trades at $22.15, up 0.36% with neutral technical signals. The stock shows modest valuation metrics with P/E of 10.85 and P/S of 0.67, while recent earnings show mixed results with Q1 2026 beating expectations. Revenue growth remains stable at $10.25B for 2025, though profit margins have compressed from historical levels. The company maintains strong cash flow generation and recently launched new product innovations including protein soups and gluten-free options.

CPB offers value investors an attractive 7% dividend yield and reasonable valuation, but faces margin pressure and competitive headwinds. Analyst consensus leans cautious with 58.6% hold ratings, though recent product launches and cost initiatives provide potential catalysts. Key risks include ongoing margin compression and consumer spending sensitivity in the current economic environment.

Koninklijke Philips NV

PHG trades at $27.34, down 0.22% on the day, with a bearish technical signal despite recent earnings beats. The company shows improving fundamentals with net income turning positive to $895M in 2025 after previous losses, supported by strong operating cash flow of $1.17B. Recent FDA clearances for AI-powered medical devices and strategic healthcare partnerships demonstrate innovation momentum.

The stock presents a mixed outlook with 41% analyst buy ratings but bearish technical indicators. Key opportunities include AI healthcare adoption and margin expansion, while risks involve competitive pressures and debt levels. Valuation appears reasonable with P/E of 24.01 and P/S of 1.31, but requires monitoring of execution against growth expectations.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Campbell Soup Co.

With a history that dates back around 150 years, Campbell Soup is now a leading manufacturer and marketer of branded convenience food products, most notably soup. The firm's product assortment includes well-known brands like Campbell's, Pace, Prego, Swanson, V8, and Pepperidge Farm. Following the sale of its international snacking operations, which wrapped in calendar 2019, the firm derives nearly all of its sales from its home turf. Campbell has made a handful of acquisitions to reshape its product mix the past few years, including the tie-up with Snyder's-Lance (completed in March 2018), which enhances its exposure to the faster-growing on-trend snack food aisle, complementing its Pepperidge Farm lineup.

Read more on CPB

About Koninklijke Philips NV

Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.

Read more on PHG